Is the media storm around Angelina Jolie raising awareness or increasing misunderstanding?

The following is an excerpt.

Angelina Jolie’s New York Times op-ed about her preventative double mastectomy continues to generate news and commentary. For those who somehow missed the many headlines, Jolie decided to undergo these surgeries because a genetic test determined that she carries mutations in the BRCA1 gene, purportedly leading (in her case) to an 87% chance of developing breast cancer. She felt that a mastectomy, which will greatly lower her risk, was the way to be proactive and take control of the situation.

As many have noted, baring such intimate details to the world took courage, and may inspire women to be more proactive about their health. But the information she shared can also easily be misunderstood.

Read the full story here: Cancer Inc.

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: The evolutionary history of the COVID-19 coronavirus

Infographic: The evolutionary history of the COVID-19 coronavirus

Reuters analysed over 185,000 genome samples from the Global Initiative on Sharing All influenza Data (GISAID), the largest database of ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend